I was actually quite happy with these “reasons" being brought up the patent examiner since if Rothman patents (which are granted) cover MRD then we have granted coverage of MRD already (RAC owns the Rothman patents).
The Nagler 1 trial is a bit silly since the patent was submitted before the results of Nagler 1 were known.
SS seems to have continued to miss that we have 4 granted US patents already and a whole lot more working their way through the patent process.
Finally all of this is irrelevant since the major focus of the company is on the FTO opportunity.
General Comments / Chat, page-4121
-
-
- There are more pages in this discussion • 7,194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.73 |
Change
0.170(10.9%) |
Mkt cap ! $294.7M |
Open | High | Low | Value | Volume |
$1.57 | $1.73 | $1.57 | $550.9K | 332.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $1.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.73 | 999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.710 |
1 | 310 | 1.670 |
1 | 836 | 1.660 |
1 | 9750 | 1.655 |
4 | 64751 | 1.650 |
Price($) | Vol. | No. |
---|---|---|
1.730 | 999 | 1 |
1.740 | 9900 | 1 |
1.745 | 1146 | 1 |
1.750 | 14309 | 3 |
1.755 | 990 | 1 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |